Comprehensive data on the US and global cannabis industry — market size, employment, tax revenue, consumer demographics, product segments, state-by-state performance, and policy timeline.
Total legal cannabis sales (medical + recreational) in billions USD.
2024 US cannabis sales breakdown by product category.
Declining share, stable revenue
Fastest growing segment
Steady growth, gummies dominant
Growing with dabbing culture
Emerging wellness segment
Stable medical use
Beverages, accessories
2024 cannabis sales and tax revenue by state.
| State | Total Sales | Tax Revenue | Dispensaries | YoY Growth |
|---|---|---|---|---|
| California | $5.3B | $1.1B | 1,247 | +8% |
| Colorado | $2.1B | $423M | 892 | +3% |
| Michigan | $3.0B | $285M | 456 | +22% |
| Illinois | $1.8B | $562M | 312 | +15% |
| Washington | $1.6B | $559M | 634 | +5% |
| Florida | $1.9B | $95M | 876 | +18% |
| Nevada | $1.0B | $215M | 387 | +7% |
| Oregon | $1.1B | $165M | 521 | +2% |
| Arizona | $1.4B | $252M | 289 | +25% |
| New York | $0.8B | $120M | 267 | +180% |
280,000+ full-time equivalent jobs in the US cannabis industry as of 2024.
• Cannabis is one of the fastest-growing job sectors in the US, adding 25,000+ jobs annually
• Average dispensary budtender salary: $35,000–$55,000 + tips
• Master grower / cultivation director: $75,000–$150,000
• Cannabis compliance officer: $60,000–$100,000
• Extraction technician: $45,000–$80,000
• Cannabis attorney: $150,000–$300,000+
California passes Prop 215 — first medical cannabis law
Colorado & Washington legalize recreational cannabis
First recreational sales begin in Colorado (Jan 1)
Farm Bill legalizes hemp/CBD federally
New Jersey, Arizona, Montana, South Dakota vote yes
New York, New Mexico, Virginia legalize
Maryland, Missouri, Rhode Island legalize
Minnesota, Delaware legalize; Ohio votes yes
Federal rescheduling process begins (Schedule III)
Projected: 30+ recreational states; federal banking reform
International cannabis market data and legal status overview.
| Country | Market Size | Legal Status | Growth |
|---|---|---|---|
| United States | $38.4B | State-by-state legal | +14% |
| Canada | $4.8B | Fully legal (2018) | +8% |
| Germany | $1.2B | Medical + Recreational (2024) | +340% |
| Australia | $0.8B | Medical only | +45% |
| Netherlands | $0.6B | Tolerated / Pilot program | +12% |
| Israel | $0.4B | Medical + Export | +28% |
| United Kingdom | $0.3B | Medical only (2018) | +35% |
| Global Total | $57.2B | All markets combined | +18% |